Introducing FibroScan: Revolutionising Liver Health Care
RMS is pleased to introduce a new, cutting-edge FibroScan service, designed specifically for NHS Trusts and Hospitals, with the aim of transforming liver health care.
Working with our trusted partners, Tawazun Health, we can deliver an end-to-end FibroScan solution to reduce long waiting lists for liver scans.
Why FibroScan?
FibroScan is a state-of-the-art liver scanning solution that identifies liver fibrosis and disease, enabling early detection and intervention.
Recent NICE guidelines have underscored the significance of expanding FibroScan services beyond specialist and secondary care to community and primary care areas, making it more accessible to patients in need.
The scan helps doctors understand the extent of liver scarring, also known as liver fibrosis, enabling early detection and intervention.
Streamlined Patient Care
One of the major hurdles faced by NHS Trusts is the lack of capacity to deliver FibroScans promptly. RMS, and our expert partners, can manage the entire process, providing the necessary resources, equipment, and reporting from specialist providers.
Our plug-and-play offering ensures a simple and hassle-free integration of FibroScan services into your healthcare facility, reducing setup time significantly.
The Power of Early Identification
FibroScan has been proven to be highly successful in the early identification of liver disease and fibrosis. The scan gauges the extent of liver damage by examining liver stiffness and any fatty changes. These measurements help doctors triage appropriate referrals so they only seek specialist help for those who need it.
For example, suppose a GP finds advanced liver scarring with the FibroScan. In that case, they can refer the patient to a specialist for treatment, which may include blood tests and a liver biopsy to examine the scar tissue further.
FibroScan empowers patients to make better lifestyle and health choices, improving liver function and overall well-being.
Industry Leading Experts
Louise Campbell is the Founder and Medical Director of Tawazun Health. Louise has over 40 years’ experience working in the Healthcare Industry in the UK and elsewhere in the world. Louise is one of the world’s leading exponents of FibroScan technology and being awarded a Fellowship of the Royal College of Physicians for patient pathway and early intervention in the areas of liver-related conditions and type-2 diabetes and cardiovascular disease, enabling individuals, physicians, and healthcare professionals to make superior health and lifestyle choices.
Louise personally completed in excess of 15,000 FibroScan exams, making her also one of the world’s leading clinical operators in this field.
Regulated for Peace of Mind
At RMS, patient safety and quality of care are our top priorities. That’s why our Fibroscan solution, delivered through our trusted partner, is CQC assessed (rated good with outstanding leadership) and regulated, offering you complete peace of mind.
You can rest assured that every step of the process adheres to the highest industry standards and guidelines.
Contact us
Contact us today to learn more about how RMS can help you bring FibroScan to your patients and NHS Trust.
The RMS team will respond to your enquiry within 24hrs.
A FibroScan of the liver is a non-invasive ultrasound that uses sound waves to measure liver stiffness, which can indicate the extent of liver scarring (fibrosis) and steatosis (fatty change). This tool helps in assessing the health of liver tissue, which is particularly useful for monitoring diseases like hepatitis C, which can lead to advanced fibrosis or cirrhosis if untreated.
By evaluating how much scarring is present, a liver scan FibroScan can give a fibrosis score that indicates whether a patient has a healthy liver or is at a higher risk of complications from severe scarring. This helps guide decisions on the necessity for liver transplantation.
While a liver FibroScan provides valuable information about liver scarring and fatty change, it is not specifically designed to identify liver cancer. Its primary role is to assess the extent of fibrosis and steatosis in the liver cells, helping manage chronic liver diseases.
For the detection of liver cancer, doctors typically recommend more targeted liver scans or liver biopsies, which can accurately distinguish between benign and malignant liver tissue changes.
A FibroScan is an advanced type of ultrasound. A standard ultrasound is a versatile imaging technique that can visualise the structure of liver tissue, detect masses, and guide procedures like liver biopsies. On the other hand, FibroScan specifically measures liver stiffness to evaluate fibrosis and steatosis grades, offering a quantifiable fibrosis score.
